- Country: Czech Republic
- Summary: Extension of Assurance Software for Microsoft Iv [2025] Licenses [2025]
- CZT Ref No: 126607700
- Deadline: 14 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 248750
- Notice Type: Tender
- Document Ref. No.: 613210-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is to ensure the extension of the Assurance software for Microsoft licenses according to the specifications and under the conditions specified in the relevant Annex 2 of the tender documentation (sample of the contract).
Extension of Assurance Software for Microsoft License Pursuant to Specifications and under the conditions specified in the relevant Annex 2 of the tender documentation (contract sample).
years "in the range of 250 licenses
Assurance pro licence Microsoft IV [2025]
Contract Type: services - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINExtension of Assurance Software for Microsoft Iv [2025] Licenses [2025] - Czech Republic Tender
The MASARYK ONCOLOGY INSTITUTE, a Government sector organization in Czech Republic, has announced a new tender for Extension of Assurance Software for Microsoft Iv [2025] Licenses [2025]. This tender is published on CzechRepublicTenders under CZT Ref No: 126607700 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-14.
The estimated tender value is CZK 248750, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
